Why Daiichi Sankyo is betting early on SylamoreBio’s SyLEC delivery platform for CNS programs
SylamoreBio partners with Daiichi Sankyo to test SyLEC CNS delivery technology. Find out what this collaboration changes for brain drug development.
Pharma & Biotech